In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 932-22-9, name is 4,5-Dichloro-3(2H)-pyridazinone, introducing its new discovery. Application of 932-22-9
The invention encompasses imidazo[ 1,2-a]pyridine and imidazo[ 1,2-b]pyridazine derivatives which selectively inhibit microtubule affinity regulating kinase (MARK) and are therefore useful for the treatment or prevention of Alzheimer’s disease.Pharmaceutical compositions and methods of use are also included.
The reactant in an enzyme-catalyzed reaction is called a substrate. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.I hope my blog about 932-22-9 is helpful to your research. Application of 932-22-9
Reference：
Pyridazine – Wikipedia,
Pyridazine | C4H4N2226 – PubChem